
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 16.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
5.87 M |
Marktkapitalisierung |
$ 15.3 M |
EBITDA (LTM) |
$ -3.17 M |
P/E (LTM) |
- |
P/S (LTM) |
0.73 |
EPS (LTM) |
-0.71 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Castle Biosciences
CSTL
|
$ 20.34 | 1.52 % | $ 590 M | Nasdaq Global Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 17.23 | 5.0 % | $ 521 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 117.53 | 2.23 % | $ 14.7 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 114.64 | -0.4 % | $ 9.46 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 113.12 | -0.54 % | $ 34.4 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 140.75 | 0.29 % | $ 6.58 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 3.81 | 59.41 % | $ 5.07 M | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 21.51 | 1.7 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 94.64 | -1.51 % | $ 6.39 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | - | $ 7.96 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 142.98 | 0.74 % | $ 22.7 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 419.78 | -0.5 % | $ 12.1 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 076.36 | -0.63 % | $ 22.2 B | NYSE,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Natera
NTRA
|
$ 204.47 | -0.22 % | $ 20.1 B | Nasdaq Global Select Market,SPB | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Personalis
PSNL
|
$ 8.36 | 5.19 % | $ 746 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 156.87 | 0.5 % | $ 7.78 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
NeoGenomics
NEO
|
$ 8.81 | -1.01 % | $ 1.13 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.99 | -1.4 % | $ 425 M | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 3.77 | -1.18 % | $ 349 M | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 448.05 | -0.79 % | $ 169 B | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.86 | 0.49 % | $ 25.5 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 5.91 | 3.5 % | $ 247 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.41 | 2.52 % | $ 5.54 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 253.48 | -1.49 % | $ 21.1 B | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 337.32 | -1.15 % | $ 20.1 B | NYSE,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 53.51 | -0.28 % | $ 3.2 B | Nasdaq Global Select Market,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.62 | 2.58 % | $ 223 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Exagen
XGN
|
$ 4.09 | 6.79 % | $ 88.2 M | Nasdaq Global Market | ||
|
Neogen Corporation
NEOG
|
$ 8.6 | -2.66 % | $ 1.87 B | Nasdaq Global Select Market,SPB |